Objective: To perform a review of soft tissue tumors in palaeopathology. Methods: Examination of palaeopathological literature. Results: Up to now, observations of neoplastic soft tissue lesions in mummified remains are limited to 15 cases, and only 4 of them present malignancies; 14 cases of calcified benign tumors, including 13 neoplasms of the female reproductive system and 1 teratoma, are also documented. Conclusions: The main reasons for the rarity of soft tissue tumors in palaeopathology, especially of malignancies, are apparently the short life span of past populations, the scarcity of mummified remains available in comparison with skeletal remains, and technical difficulties in the detection of neoplastic lesions in mummified tissues.

Keywords:
Cancer, Mummies, Palaeopathology, Soft tissue tumors
1.
Strouhal E: Malignant tumors in the Old World. Paleopathol Newsl 1994;85:1–6.
2.
Capasso L: Antiquity of cancer. Int J Cancer 2005;113:2–13.
3.
Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
4.
Fornaciari G, Giuffra V: Les lésions tumorales osseuses; in Charlier P (ed): Ostéo-archéologie et techniques médico-légales: tendances et perspectives. Pour un ‘Manuel pratique de paléopathologie humaine’. Paris, De Boccard, 2008, pp 393–412.
5.
Zimmerman MRA: Paleohistology of ancient tissue tumors. Paper presented at the 22nd Annual Meeting of the Paleopathology Association held in Oakland, CA, on 28–29 March, 1995 (abstract). Paleopathol Newsl 1995;90(suppl):14–15.
6.
Zimmerman MRA, Aufderheide C: Seven mummies of the Dakhleh oasis, Egypt: seventeen diagnoses. Paleopathol Newsl 2010;150:16–23.
7.
Gerszten E, Allison M: Human soft tissue tumors in Paleopathology; in Ortner DJ, Aufderheide AC (eds): Human Paleopathology: Current Syntheses and Future Options. Washington, Smithsonian Institute, 1991, pp 260–277.
8.
Fornaciari G: Adenocarcinoma in the mummy of Ferrante I of Aragon, King of Naples (1431–1494). Paleopathol Newsl 1993;82:5–8.
9.
Fornaciari G: Malignant tumor in the mummy of Ferrante Ist of Aragon, King of Naples (1431–1494). Med Secoli 1994;6:139–146.
10.
Marchetti A, Pellegrini S, Bevilacqua G, Fornaciari G: K-RAS mutation in the tumour of Ferrante I of Aragon, King of Naples. Lancet 1996;347:1272.
11.
Ottini L, Falchetti M, Marinozzi S, Angeletti LR, Fornaciari G: Gene-environment interactions in the pre-Industrial Era: the cancer of King Ferrante I of Aragon (1431–1494). Hum Pathol 2011;42:332–339.
12.
Fornaciari G, Bruno J, Corcione N, Tornaboni D, Castagna M: Un cas de tumeur maligne primitive de la region naso-orbitaire dans une momie de la basilique de S. Domenico Maggiore à Naples (XVIe siècle); in Capasso L (ed): Advances in Paleopathology: Proceedings of the VII European Meeting of the Paleopathology Association: Lyon, September 1988. J Paleopathol Monogr Publ. Chieti, Solfanelli, 1989, pp 65–69.
13.
Urteaga OB, Pack GT: On the antiquity of melanoma. Cancer 1966;19:607–610.
14.
Granville AB: An essay on Egyptian mummies. Philos Trans R Soc Lond 1825;1:269–316.
15.
Aufderheide C, Rodriguez-Martin C: The Cambridge Encyclopedia of Human Paleopathology. Cambridge, Cambridge University Press, 1998.
16.
Zimmerman MRA: A possible histiocytoma in an Egyptian mummy. Arch Dermatol 1981;117:364–365.
17.
Sandison AT: Diseases of the skin; in Brothwell DR, Sandison AT (eds): Diseases in Antiquity. Springfield, Thomas, 1967, pp 449–463.
18.
Reyman TA, Peck WH: Egyptian mummification with evisceration per ano; in Cockburn A, Cockburn E, Reyman TA (eds): Mummies, Disease and Ancient Cultures. Cambridge, Cambridge University Press, 1983, pp 353–394.
19.
Fulcheri E: Case no. 27: verruca vulgaris. Paleopathol Club Newsl 1987;31:2.
20.
Horne PD, Kawasaki SQ: The prince of El Plomo: a paleopathological study. Bull NY Acad Med 1984;60:925–931.
21.
Horne PD: Case no. 23: angiokeratoma circumscription. Paleopathol Club Newsl 1986;27:1.
22.
Ventura L, Miranda G, Mercurio C, Ciocca F, Fornaciari G: Paleopathology of the natural mummies of the inner Abruzzo region (XVIII–XIX century). Med Secoli 2006;18:875–896.
23.
Fornaciari G, Zavaglia K, Giusti L, Vultaggio C, Ciranni R: Human papillomavirus in a 16th century mummy. Lancet 2003;362:1160.
24.
Strouhal E, Jungwirth J: Ein verkalktes Myoma uteri aus der späten Römerzeit in Ägyptisch-Nubien. Mitt Anthropol Ges 1977;107:215–221.
25.
Kramar C, Baud CA, Lagier R: Presumed calcified leiomyoma of the uterus. Morphologic and chemical studies of a calcified mass dating from the Neolithic period. Arch Pathol Lab Med 1983;107:91–93.
26.
Baud CA, Kramar C: Soft tissue calcifications in pathology; in Ortner DJ, Aufderheide AC (eds): Human Paleopathology: Current Syntheses and Future Options. International Congress of Anthropological and Ethnological Sciences (12, Zagreb, 1988). Washington, Smithsonian Institute, 1991, pp 87–89.
27.
Quintelier K: Calcified uterine leiomyomata from a post-medieval nunnery in Brussels, Belgium. Int J Osteoarchaeol 2009;19:436–442.
28.
Jiménez-Brobeil SA, Botella Lopez MC, Ruiz Rodriguez L: A contribution to Medieval pathological gynaecology. J Paleopathol 1992;4:155–161.
29.
Capasso L: I fuggiaschi di Ercolano. Paleobiologia delle vittime dell’eruzione vesuviana del 79 d.C., Roma, L’ERMA di Bretschneider, 2001.
30.
La Verghetta M, Capasso L: Paleopathology of uterine fibroma: direct and indirect sources (Italy); in La Verghetta M, Capasso L (eds): Proceedings of the XIII European Meeting of the Paleopathology Association (Chieti, Italy). Teramo, Edigraphital, 2001, pp 145–148.
31.
Capasso L, Baggieri G, Di Tota G, Meucci C: Probabile fibroleiomioma uterino calcificato dalla necropoli di Alfedena (L’Aquila), circa VI–IV secolo a.C. (Età del Ferro). Antropol Contemp 1994;17:13–18.
32.
Scheidegger S: Ursachen und Verbreitung der Tumoren. Beiträge zur Paläopathologie. Tagungsberichte zum Paläopathologichen Symposium (Liestal, BL, 21–23 Juni 1984). Archäologie Museum 1990;18:38–41.
33.
Charlier P, Huynh-Charlier I, Brun L, Devisme L, Catalano P: Un tératoma mature médiastinal vieux de 1800 ans. Ann Pathol 2009;29:67–69.
34.
David R, Zimmerman R: Cancer: an old disease, a new disease or something in between? Nat Rev Cancer 2010;10:728–733.
35.
Thillaud PL: Paléopathologie du cancer: continuité ou rupture? Bull Cancer 2006;93:767–773.
36.
Zimmerman MRA: An experimental study of mummification pertinent to the antiquity of cancer. Cancer 1977;40:1358–1362.
37.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
38.
Selo-Ojeme D, Lawal O, Shah J, Mandal R, Pathak S, Selo-Ojeme U, Samuel D: The incidence of uterine leiomyoma and other pelvic ultrasonographic findings in 2,034 consecutive women in a north London hospital. J Obstet Gynaecol 2008;28:421–423.
39.
Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, Kobayashi H, Fujii S, Konishi J: Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Eur Radiol 2000;10:780–782.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.